Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Talk Ten Tuesdays 500th Episode - Q&A with Chuck Buck

MedLearn Media celebrates its 500th episode of Talk Ten Tuesday with an interview with the broadcast's host and creator, Chuck Buck, to look back on where the informative webcast has been and where it's headed.


News provided by

MedLearn Media, Inc.

Mar 15, 2022, 09:00 ET

Share this article

Share toX

Share this article

Share toX


ST. PAUL, Minn., March 15, 2022 /PRNewswire-PRWeb/ -- As the 500th episode of the Talk Ten Tuesday approaches, MedLearn Media editor Jason Henninger chatted with the broadcast's host and creator, Chuck Buck, to look back on where the informative webcast has been and where it's headed.

Jason Henninger: How did Talk Ten Tuesday come to be?

It was exciting to follow and ask, is it ever going to happen? And then, it did happen. It all made for great radio and great stories, because of the suspense and controversy. It was a fantastic experience as a journalist and as a producer.

Post this

Chuck Buck: We had already started with RACmonitor in 2008. I got the idea on the flight to a meeting in New Jersey with a RACmonitor sponsor. While on the plane, I said to myself, we ought to do a live broadcast. I'd always been in journalism, and in broadcast either as a producer or as a talent.

I wrote the concept on the back of an air sickness bag, and I pitched Monitor Monday. We got it organized and it started in 2010. But at the same time that I was doing RACmonitor and Monitor Mondays I realized that one of the biggest issues coming up would be the United States migrating from ICD-9 to ICD-10. It had gone through a number of fits and starts during the last thirty years. There was a lot of opposition at the time. I thought, well, it's going to be controversial, and it would be interesting to see if the United States does adopt the tenth version of the International Classification of Diseases. So, we started ICD10 Monitor in 2011 and began the broadcast , "Talk Ten Tuesdays," reporting on ICD-10, so that's the genesis of Talk Ten Tuesday.

Henninger: You don't come from a coding background. What challenges did that present you?

Chuck: The biggest challenge — and I don't think I'm alone in this — is trying to understand the anatomy involved. So much of this is body parts, this piece connected to this piece. In fact, coders will often say they need to have a refresher course on anatomy and physiology. It's a challenge to understand what these very discrete codes they are really talking about. I put it in the category of lifelong learning. I can talk about body parts at a cocktail party now for about five minutes and sound pretty authoritative.

Henninger: When do you think we will move to ICD-11?

Chuck: That's a subject we talk about frequently on ICD10 Monitor and Talk Ten Tuesday. The best guess I hear is four or five years from now. ICD-11 has already been adopted in a number of countries. What happens here is that ICD-11 has to go through a clinical modification. That's going to take a couple of years. Though there are some websites up now where you can test it out, but it's a few years away from being fully implemented.

Henninger: Will ICD-11 be very different from 10?

Buck: From what I understand, it's more comprehensive and there are no printed code books involved. It will be all online. We have an excellent authority on this very subject, Mary Stanfill, who is now our ICD11 correspondent. She's an excellent writer and a subject matter expert, and she's written a few articles for us.

Henninger: Looking back over years, what stands out to you?

Buck: The projected adoption of ICD-10 was fiscal year 2015. There had been dates before that, 2013, 2014, and so forth, that got delayed and delayed. That gave us a great ride. We'd always being asked, "Are they going to adopt it now?" And no, something would always come up and delay it. The AMA at the time was opposed to it, and doctors were opposed to it. They said it was too complicated and laborious for doctors to use. It was kind of a roller coaster experience. They'd say everything is all set, then something would happen, and it would get delayed for another year. It was exciting to follow and ask, is it ever going to happen? And then, it did happen. It all made for great radio and great stories, because of the suspense and controversy. It was a fantastic experience as a journalist and as a producer.

Henninger: How has the pandemic affected the show's content?

Buck: We've been reporting on the general mistrust of medicine. COVID-19 is different from swine flu and so forth because it became highly politicized. Trump was dismissive of it. In Carl Bernstein's book, Trump said he wanted to be a cheerleader. He just wanted to bring the country good news, and he figured COVID-19 was bad news, so he tried to bat it down. So, everything associated with it, vaccines, social distancing, mask wearing, hand washing, all that became controversial and politicized.

Dr. Remer is a big advocate of vaccination, in fact she volunteers to administer vaccines. So, every time she's brought it up, we get these critical comments asking why we're talking vaccines, saying that they're experimental, they aren't proven, they use fetal tissue…all these rumors feed distrust of the vaccine.

Additionally, when the new administration came in, they focused on health equity, and of course they found health inequity for minorities. There's a common distrust of healthcare in minorities, and whose outcomes are typically worse. There are higher rates of diabetes among African Americans, higher maternal mortality, and cardiovascular issues. This spills over into what's referred to as the social determinants of health where income, living conditions, education and so forth are non-clinical factors now being considered part of the medical record.

Marry that distrust among minorities, now, to the distrust of vaccines and mask wearing. And a lot of Americans are also deferring medical attention for fear of the coronavirus. They'd rather delay getting that cardiogram or whatever diagnostic tests in person.

Henninger: How do you see the broadcast in the future?

Buck: I would really like to see us do a daily broadcast. Healthcare is massive, it's changing all the time, and we have enough content and enough interest. There are so many issues that it would be helpful for people to get updated on regularly.

Read this article on the ICD10monitor site.

About MedLearn Media, Inc.

Based in St. Paul, Minnesota, MedLearn Media, Inc., and its family of brands — MedLearn Publishing, ICD10monitor and RACmonitor — offer trusted expertise to the healthcare industry in the areas of coding, reimbursement and regulatory compliance. MedLearn Media's industry-leading resources include online news and special reports, blog articles, print and digital books, visual charts, newsletters, webcasts, seminars and on-demand content. For 30 years, healthcare organizations of all types have depended on MedLearn Media to guide them to fiscal integrity, regulatory compliance and peace of mind.

Media Contact

Catherine Wang, MedLearn Media, Inc., +1 651-292-3414, [email protected]

Twitter, Facebook

SOURCE MedLearn Media, Inc.

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.